High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer

by Eccles, D, Gerty, S, Simmonds, P
Published 2006

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

by Mavridou, D., Gornall, R., Campbell, I. G., Eccles, D. M.
Published 1998

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.

by Manolitsas, T. P., Englefield, P., Eccles, D. M., Campbell, I. G.
Published 1997

BRCA1 polymorphisms.

by Campbell, I. G., Schroff, R., Englefield, P., Eccles, D. M.
Published 1997

BRCA1 mutations in southern England.

by Eccles, D. M., Englefield, P., Soulby, M. A., Campbell, I. G.
Published 1998

Management of Hereditary Breast Cancer

by Eccles, D. M., Simmonds, P., Goddards, J., Coultas, M., Lalloo, F., Evans, G., Haites, N.
Published 1999

Understanding of BRCA VUS genetic results by breast cancer specialists

by Eccles, B. K., Copson, E., Maishman, T., Abraham, J. E., Eccles, D. M.
Published 2015

Cervical intraepithelial neoplasia in lymphoma patients: a cytological and colposcopic study.

by Hughes, R. G., Colquhoun, M., Eccles, D. M., Alloub, M., Parker, A. C., Norval, M., Smart, G. E.
Published 1989

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

by Eccles, D. M., Brett, L., Lessells, A., Gruber, L., Lane, D., Steel, C. M., Leonard, R. C.
Published 1992

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

by Maishman, T, Copson, E, Stanton, L, Gerty, S, Dicks, E, Durcan, L, Wishart, G C, Pharoah, P, Eccles, D
Published 2015

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

by Gabra, H., Taylor, L., Cohen, B. B., Lessels, A., Eccles, D. M., Leonard, R. C., Smyth, J. F., Steel, C. M.
Published 1995

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

by Robertson, L, Hanson, H, Seal, S, Warren-Perry, M, Hughes, D, Howell, I, Turnbull, C, Houlston, R, Shanley, S, Butler, S, Evans, D G, Ross, G, Eccles, D, Tutt, A, Rahman, N
Published 2012

Genetic Testing for Breast Cancer Predisposition in 1999: Which Molecular Strategy and which Family Criteria?

by Stoppa-Lyonnet, D., Caligo, M., Eccles, D., Evans, D. G. R., Haites, N. E., Hodgson, N. S., Møller, P., Morrison, P. J., Steel, C. M., Vasen, H. F. A., Chang-Claude, J.
Published 1999

Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics

by Vasen, H. F. A., Haites, N. E., Evans, D. G. R., Steel, C. M., Møller, P., Hodgson, S., Eccles, D., Morrison, P., Stoppa-Lyonnet, D., Chang-Claude, J., Caligo, M., European Familial Breast Cancer Collaborative Group
Published 1999

Utilisation of Prophylactic Mastectomy in 10 European Centres

by Evans, D. G. R., Anderson, E., Lalloo, F., Vasen, H., Beckmann, M., Eccles, D., Hodgson, S., Møller, P., Chang-Claude, J., Morrison, P., Stoppa-Lyonnet, D., Steel, M., Haites, N.
Published 1999

Cancer Genetics Services in Europe

by Hodgson, S., Milner, B., Brown, I., Bevilacqua, G., Chang-Claude, J., Eccles, D., Evans, G., Gregory, H., Møller, P., Morrison, P., Steel, M., Stoppa-Lyonnet, D., Vasen, H., Haites, N.
Published 1999

Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe

by Morrison, P. J., Steel, C. M., Vasen, H. F. A., Eccles, D., Evans, D. G. R., Møller, P., Hodgson, S., Stoppa-Lyonnet, D., Chang-Claude, J., Caligo, M., Olah, E., Haites, N. E., Nevin, N. C.
Published 1999

Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate

by Benton, M. C., Lea, R. A., Macartney-Coxson, D., Bellis, C., Carless, M. A., Curran, J. E., Hanna, M., Eccles, D., Chambers, G. K., Blangero, J., Griffiths, L. R.
Published 2015

Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer

by Møller, P., Evans, G., Haites, N., Vasen, H., Reis, M. M., Anderson, E., Apold, J., Hodgson, S., Eccles, D., Olsson, H., Stoppa-Lyonnet, D., Chang-Claude, J., Morrison, P. J., Bevilacqua, G., Heimdal, K., Mæhle, L., Lalloo, F., Gregory, H., Preece, P., Borg, Å., Nevin, N. C., Caligo, M., Steel, C. M.
Published 1999

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

by Saladores, P, Mürdter, T, Eccles, D, Chowbay, B, Zgheib, N K, Winter, S, Ganchev, B, Eccles, B, Gerty, S, Tfayli, A, Lim, J S L, Yap, Y S, Ng, R C H, Wong, N S, Dent, R, Habbal, M Z, Schaeffeler, E, Eichelbaum, M, Schroth, W, Schwab, M, Brauch, H
Published 2015